|IUPAC name||Dichloro-s-triazine-2,4,6-trione, sodium salt|
|Other names||Sodium dichloroisocyanurate|
3D model (JSmol)
|ECHA InfoCard||Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).|
|Density||0.7 g/cm³ (as granules)|
|Except where noted otherwise, data are given for|
materials in their standard state
(at 25 °C, 100 kPa)
Infobox disclaimer and references
It is the sodium salt of dichloroisocyanuric acid. Products containing sodium dichloroisocyanurate may also contain cyanuric acid. It is white in colour, and appears as crystalised granules, powder or tablets. It is a heterocyclic ring compound which is a derivative of triazine.
Ventilation exhausts or appropriate breathing apparati should be installed wherever this chemical is handled. Protective gloves and clothing should also be worn. Exposure symptoms are coughing, sore throat, redness on skin or around eyes, burns, pain and/or loss of vision. Repeated or prolonged exposure can cause dermatitis. Indigestion should be treated with rest, water to rinse out the mouth and medical attention. Vomiting should not be induced. In firefighting, drums and containers may be cooled with water spray on condition that the substance does not come into contact with water. Spills should not be washed into any public sewage system.